Ireland Prepares New Biosimilar Policy To Improve Access, Boost Industry
Executive Summary
Ireland is developing a new policy intended to increase the use of biosimilars, taking account of initiatives in other countries. The government says the aim is to help boost competition and access to cheaper biologicals.
You may also be interested in...
Switching, Substitution & Quotas: Irish Govt Wants Views On Boosting Biosimilars
Stakeholders are being asked to respond to a consultation on what steps can be taken to increase the use of biosimilars in Ireland. The generics and biosimilars industry body Medicines for Ireland has welcomed the move but says it has come very late in the day.
Switching, Substitution & Quotas: Irish Govt Wants Views On Boosting Biosimilars
Stakeholders are being asked to respond to a consultation on what steps can be taken to increase the use of biosimilars in Ireland. The generics and biosimilars industry body Medicines for Ireland has welcomed the move but says it has come very late in the day.
Biosimilar Firms Say Irish Price Deal Hinders Uptake, As Govt Plans New Policy Measures
The Irish health ministry is planning measures to boost the prescribing of biosimilar medicines, but companies marketing biosimilars say that the pricing agreement signed last year by the originator industry and the government has served to hinder uptake of their products.